Abstract

The present invention relates to the field of pharmaceutical chemistry, specifically to novel solid-state forms of Naperiglipron. More particularly, the invention relates to a novel crystalline form, an amorphous form, and novel cocrystal forms (Nicotinamide, Citric Acid, and Succinic Acid) of Naperiglipron, and processes for their preparation showing enhanced solubility and physical stability.

Creative Commons License

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.

Share

COinS